Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

UiPath's AI-driven automation momentum, strong cash position and enterprise adoption stand out against Microvast's growth, losses and liquidity strain.

UiPath Inc. (NYSE:PATH) provides an end-to-end automation platform that offers a range of robotic process automation/RPA ...

UiPath announced the expansion of its UAE footprint with the launch of Automation Cloud integrated with Microsoft Azure ...

UiPath (PATH) just checked several key boxes for investors at once, moving from GAAP losses to profit while accelerating revenue growth and doubling down on its agentic AI and automation platform ...

GitLab (GTLB) beat Q3 estimates with 25% revenue growth and operating margin reaching 18% from negative a year ago. GitLab insiders sold heavily with Director Matthew Jacobson offloading $45M in ...

The Details: UiPath reported quarterly adjusted earnings of 16 cents per share, which beat the Street estimate of 15 cents. Quarterly revenue clocked in at $411.11 million, which beat the consensus ...

UiPath could become the connective tissue linking the software sprawl that companies face. AI is helping UiPath expand the boundaries of traditional robotic process automation. Its focus on secure, ...

It allows organisations to scale from simple automation tasks to extensive agent-based automation projects within weeks. Image: Shutterstock UiPath, a global leader in agentic automation, is launching ...

On CNBC's “Mad Money Lightning Round,” Jim Cramer said he can't recommend UiPath Inc. (NYSE:PATH) as the stock just had such a big move. “It's not for me,” he added. UiPath shares climbed 40% last ...

UiPath stock surged more than 40% this week following a new collaboration with ChatGPT maker OpenAI on agentic AI technology. The rally actually started last week when UiPath announced integrations ...